Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data Volume and the Need for Clinical Decision Support in Glaucoma Care.

Ophthalmology science·2026
Same author

Extraction of Glaucoma Diagnosis, Type, and Severity from Clinical Notes using Secure Cloud-based Large Language Models.

medRxiv : the preprint server for health sciences·2026
Same author

GLLaucoMed: A Secure LLM-Powered Agentic Workflow for Automated Medication Extraction from Free-Text Glaucoma Clinical Notes.

medRxiv : the preprint server for health sciences·2026
Same author

Intraocular Pressure Measurement Variability in the Ocular Hypertension Treatment Study.

Ophthalmology. Glaucoma·2026
Same author

Optic Disc Fundus Images Retain Biometric Identity Signals Under Deep Learning.

Research square·2026
Same author

Development and Pilot Testing of a Mobile App Psychosocial Intervention for Psychological Distress in Individuals with Glaucoma.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Jun 17, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Diagnostic tools for calculation of glaucoma risk.

Steve L Mansberger1, Felipe A Medeiros, Mae Gordon

  • 1Devers Eye Institute, Legacy Health System, Portland, Oregon 97210, USA. smansberger@deverseye.org

Survey of Ophthalmology
|December 17, 2008
PubMed
Summary

Ophthalmology risk calculators aid glaucoma and ocular hypertension management. However, clinicians should use these tools as supplemental information, as they lack crucial patient-specific factors for treatment decisions.

More Related Videos

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Related Experiment Videos

Last Updated: Jun 17, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Area of Science:

  • Ophthalmology
  • Medical Informatics

Background:

  • Risk calculators are established tools in various medical fields for guiding clinical decisions.
  • Their application in ophthalmology, particularly for ocular hypertension and glaucoma, is evolving.
  • Existing calculators in medicine assess risks for conditions like chromosomal abnormalities, osteoporosis, and cardiovascular disease.

Purpose of the Study:

  • To review the current state of risk calculators in ophthalmology.
  • To evaluate their utility in managing ocular hypertension and glaucoma.
  • To highlight limitations and provide guidance for their clinical application.

Main Methods:

  • Literature review of existing risk calculators in ophthalmology.
  • Analysis of the components and limitations of current tools.
  • Comparison with risk calculators used in other medical specialties.

Main Results:

  • Risk calculators can potentially streamline management and support evidence-based treatment for ocular hypertension and glaucoma.
  • Current ophthalmology risk calculators lack critical data such as patient life expectancy and adherence to long-term treatments like eye drops.
  • These tools are not yet comprehensive enough for sole decision-making.

Conclusions:

  • Risk calculators offer supplemental value in managing ocular hypertension and glaucoma.
  • Ophthalmologists must integrate calculator outputs with clinical judgment and patient-specific factors.
  • Further development is needed to incorporate more comprehensive patient data for improved clinical utility.